An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

Malignant pleural effusion (MPE) is a devastating sequela associated with cancer. Talc pleurodesis is a common treatment strategy for MPE but has been estimated to be unsuccessful in up to 20 –50% of patients. ...

Source: BMC Cancer - June 24, 2019 Category: Cancer & Oncology Authors: Tim N. Beck, Alexander Y. Deneka, Louis Chai, Colin Kanach, Priya Johal, Nicolas J. Alvarez, Yanis Boumber, Erica A. Golemis and Glenn W. Laub Tags: Research article Source Type: research